BioTech/Drugs - Burlingame, CA, US
Inflammatix is developing an innovative point-of-care instrument platform to be used with a rapid (<30-minute) point-of-care test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response diagnostics. Our HostDx test rapidly informs the clinician about the likelihood of bacterial or viral infection and the need for ICU level care in the emergency department. Faster results may translate into more timely and appropriate therapy and level of care decisions for better patient outcomes.
Outlook
Pardot
WordPress.org
GoDaddy Hosting
Greenhouse.io
Mobile Friendly